Form 8-K - Current report:
SEC Accession No. 0001213900-25-059690
Filing Date
2025-06-30
Accepted
2025-06-30 16:31:00
Documents
19
Period of Report
2025-06-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0247461-8k_inmune.htm   iXBRL 8-K 29057
2 OPINION OF SICHENZIA ROSS FERENCE CARMEL LLP ea024746101ex5-1_inmune.htm EX-5.1 12327
3 FORM OF SECURITIES PURCHASE AGREEMENT, DATED JUNE 27, 2025 ea024746101ex10-1_inmune.htm EX-10.1 207212
4 FORM OF PLACEMENT AGENCY AGREEMENT, DATED JUNE 27, 2025 ea024746101ex10-2_inmune.htm EX-10.2 48004
5 PRESS RELEASE, DATED JUNE 27, 2025 ea024746101ex99-1_inmune.htm EX-99.1 10069
6 PRESS RELEASE, DATED JUNE 30, 2025 ea024746101ex99-2_inmune.htm EX-99.2 9911
7 GRAPHIC ex5-1_001.jpg GRAPHIC 6148
8 GRAPHIC ex99-1_001.jpg GRAPHIC 1870
  Complete submission text file 0001213900-25-059690.txt   574524

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE inmb-20250627.xsd EX-101.SCH 3017
10 XBRL LABEL FILE inmb-20250627_lab.xml EX-101.LAB 34239
11 XBRL PRESENTATION FILE inmb-20250627_pre.xml EX-101.PRE 22360
21 EXTRACTED XBRL INSTANCE DOCUMENT ea0247461-8k_inmune_htm.xml XML 3679
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 251092536
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)